N,N'-Dicyclohexylurea

CAS No. 2387-23-7

N,N'-Dicyclohexylurea( 1,3-Dicyclohexylurea | AURORA KA-3582 | Dicyclohexylurea | Dicyclohexylcarbodiamide | NSC 17013 | DCU )

Catalog No. M27666 CAS No. 2387-23-7

N,N'-Dicyclohexylurea is a soluble epoxide hydrolase (sEH) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
500MG 357 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N,N'-Dicyclohexylurea
  • Note
    Research use only, not for human use.
  • Brief Description
    N,N'-Dicyclohexylurea is a soluble epoxide hydrolase (sEH) inhibitor.
  • Description
    N,N'-Dicyclohexylurea is a soluble epoxide hydrolase (sEH) inhibitor.
  • In Vitro
    ——
  • In Vivo
    1,3-Dicyclohexylurea (Sprague Dawley rats, 30 mg/kg, Orally, once) shows antihypertensive efficacy when milled to reduce particle size, thus improving dissolution and oral bioavailability.
  • Synonyms
    1,3-Dicyclohexylurea | AURORA KA-3582 | Dicyclohexylurea | Dicyclohexylcarbodiamide | NSC 17013 | DCU
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2387-23-7
  • Formula Weight
    224.348
  • Molecular Formula
    C13H24N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (22.29 mM助)
  • SMILES
    O=C(NC1CCCCC1)NC1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Valdivia C, et al. Bioactive alkenylphenols from Piper obliquum. Bioorg Med Chem. 2008 Apr 1;16(7):4120-6.
molnova catalog
related products
  • 6,6-Dimethyl-2,2-dip...

    6,6'-Dimethyl-2,2'-dipyridyl (6,6'-Bi-2-picoline) is a novel time-resolved fluorescent immunoassay (TRFIA) chelate with a good bactericidal effect for the study of rosacea.

  • Clanfenur

    Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.

  • RGX-104 HCl

    RGX-104 is a liver X receptor (LXR) agonist with potential immunomodulating and antineoplastic activities. It modulates innate immunity via transcriptional activation of the ApoE gene.